Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 366,178,112
  • Shares Outstanding, K 2,684,000
  • Annual Sales, $ 71,890 M
  • Annual Income, $ 16,540 M
  • 36-Month Beta 0.78
  • Price/Sales 5.11
  • Price/Cash Flow 16.53
  • Price/Book 5.13

Price Performance

See More
Period Period Low Period High Performance
1-Month
129.05 +5.48%
on 09/29/17
137.52 -1.02%
on 10/12/17
+1.67 (+1.24%)
since 09/15/17
3-Month
129.05 +5.48%
on 09/29/17
137.52 -1.02%
on 10/12/17
+3.52 (+2.65%)
since 07/14/17
52-Week
109.32 +24.52%
on 12/07/16
137.52 -1.02%
on 10/12/17
+18.56 (+15.79%)
since 10/14/16

Most Recent Stories

More News
5 Earnings All Stars to Start Off the Week

Nervous about earnings season? This week, it pays to check in with these bellwether stocks.

OMC : 73.93 (-1.61%)
MS : 48.94 (+1.33%)
JNJ : 136.12 (-0.23%)
CSX : 52.84 (+0.02%)
UNH : 193.20 (+0.35%)
J&J's Psoriasis Drug Stelara Gets FDA Nod for Adolescent Use

Johnson & Johnson (JNJ) announced approval of label expansion for its plaque psoriasis drug, Stelara, to include adolescent patients.

CELG : 136.71 (+0.18%)
JNJ : 136.12 (-0.23%)
ABBV : 91.04 (+0.41%)
PFE : 35.98 (-0.99%)
Leader of Johnson & Johnson 3D Printing Center of Excellence Outlines Advantages of Customized Knee Implants

ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants customized to fit each patient's unique anatomy, today announced that, while the industry has begun to...

CFMS : 3.48 (-1.97%)
JNJ : 136.12 (-0.23%)
MedTech Players Eyeing Emerging Market Growth Opportunities

The gloomy eco-political scenario in the United States and Europe points toward the fact that emerging geographies are playing a crucial role in the growth of the MedTech space globally.

ABT : 54.63 (-0.04%)
BSX : 29.16 (-0.95%)
JNJ : 136.12 (-0.23%)
TMO : 191.28 (-0.59%)
MDT : 77.73 (-0.44%)
J&J (JNJ) to Kickstart Pharma Q3 Earnings: What's in Store?

J&J's (JNJ) sales and earnings growth are expected to accelerate in third and fourth quarters. The company expects organic sales growth of 4% in the second half of the year.

JNJ : 136.12 (-0.23%)
Stock Market News For Oct 12, 2017

Markets notched up record highs following release of the Federal Open Market Committee minutes on Wednesday.

JBLU : 20.24 (-0.64%)
ALGT : 139.90 (-0.32%)
JNJ : 136.12 (-0.23%)
DAL : 53.62 (-0.63%)
MCD : 165.01 (-0.22%)
Johnson & Johnson Innovation, JLABS Releases Impact Report

https://mma.prnewswire.com/media/582279/Johnson_and_Johnson_Innovation_LLC___JLABS.jpg

JNJ : 136.12 (-0.23%)
Johnson & Johnson Innovation, JLABS Releases Impact Report

https://mma.prnewswire.com/media/582279/Johnson_and_Johnson_Innovation_LLC___JLABS.jpg

JNJ : 136.12 (-0.23%)
Asian shares mostly rise, taking cue from Wall Street gains

TOKYO (AP) — Asian shares advanced Thursday, taking their cue from the latest record highs on Wall Street. Chinese investors are holding back ahead of a key communist party meeting next week.

JBLU : 20.24 (-0.64%)
C : 71.77 (-0.47%)
JPM : 97.84 (+2.07%)
V : 108.30 (-0.33%)
KR : 20.44 (-4.04%)
JNJ : 136.12 (-0.23%)
LUV : 58.88 (-0.41%)
DAL : 53.62 (-0.63%)
Markets Right Now: Modest gains for stocks set more records

NEW YORK (AP) — The latest on developments in financial markets (All times local):

JBLU : 20.24 (-0.64%)
JNJ : 136.12 (-0.23%)
DAL : 53.62 (-0.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Support & Resistance

2nd Resistance Point 138.03
1st Resistance Point 137.07
Last Price 136.12
1st Support Level 135.35
2nd Support Level 134.59

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart